ASH2024注目テーマ⑥注目演題「#681」

小児の再発・難治性B-ALLにおける
CD19/22二重標的CAR-T療法
臨床第Ⅱ相試験で有効性と安全性を確認 Safety and Efficacy of Bicistronic CD19/CD22 CAR T Cell Therapy in Childhood B Cell Acute Lymphoblastic Leukemia (#681)

Xinyu Wan（Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children’s Medical Center, Shanghai, China）